Autism

This is our library on scientific research related to CBD, the Endocannabinoid System, other cannabinoids and Autism. Below you will find a list of conditions for which there are one or more scientific studies of CBD. The source of these scientific studies relates primarily to PubMed, an online service of the U.S. National Library of Medicine.

Important: The studies that are listed by PubMed are for the most part preclinical research. These relate in most cases to animal experiments with isolated CBD (pure CBD) and not fully extracted CBD extract. Although mammals have cell receptors that respond to cannabinoid compounds, the data collected from animal studies are not always 1: 1 applicable to humans. Always check with your physician before starting a new dietary supplement program. Learn more at: The Basics of CBD Oils and Cannabis as a Therapeutic Agent

A novel approach to the symptomatic treatment of autism
Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders 
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
Endocannabinoid Signaling in Autism
Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain
Targeting the endocannabinoid system in the treatment of fragile X syndrome

Send this to a friend